Alpha Tau Medical Ltd Cl A (DRTS)

$5.05 +0.09 (1.81%)
Market Cap 428.34M
Revenue (ttm) 0.00
Net Income (ttm) -31.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.08
Volume 172,500
Avg Vol 131,658
Day's Range N/A - N/A
Shares Out 84.82M
Stochastic %K 96%
Beta 1.06
Analysts Strong Sell
Price Target $8.67

Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 577 4115
Address:
Kiryat HaMada St. 5, Jerusalem, Israel
StockScanners
StockScanners Dec. 13 at 8:34 PM
$DRTS reached 5.49
0 · Reply
WeedMan5000
WeedMan5000 Dec. 12 at 8:17 PM
$DRTS 1m volume sends this thing .20c swings, insane price action , an ounce of any volume and we might see a move here
0 · Reply
Freddie___Mac
Freddie___Mac Dec. 12 at 2:35 PM
$DRTS low liquidity as insiders own a lot. Just the CEO own about 15% of the company... which is ofc a positive indication
0 · Reply
StonkCrasher420
StonkCrasher420 Dec. 11 at 5:02 PM
$DRTS Showing a lot of strength here. Consolidation in this range and a push to $7-$8 on the next wave of news would be fantastic
1 · Reply
BuyZoneSn1perz
BuyZoneSn1perz Dec. 11 at 12:12 PM
$DRTS low-liquidity setup, if bids keep absorbing sells this coil could resolve up
0 · Reply
Greenpa
Greenpa Dec. 11 at 12:38 AM
$DRTS If Sidoti conference was recorded, I urge a listen by Citi and retail. Any of prostate, pancreatic and gioblastoma would be epic. Two or more is not out of the question given initial data. It is the abscopal effect that would enable a very interesting pathway for treatment of solid and difficult to treat and/or resect tumors.
2 · Reply
SkylineX88v
SkylineX88v Dec. 10 at 9:09 PM
$DRTS low-liquidity setup, if bids keep absorbing sells this coil could resolve up
0 · Reply
Greenpa
Greenpa Dec. 10 at 8:45 PM
$DRTS Why would anyone pay attention to Citi lowering target to $7 following successful administration of localized alpha radiation for otherwise incurable brain tumors? Which hedge fund clients of Cit want in?
0 · Reply
WallStWireAds
WallStWireAds Dec. 10 at 7:38 PM
$DRTS
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 7:14 PM
Citigroup has adjusted their stance on Alpha Tau Medical ( $DRTS ), setting the rating to Buy with a target price of 8 → 7.
1 · Reply
Latest News on DRTS
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University

Dec 9, 2025, 9:00 AM EST - 4 days ago

Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University

Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 20, 2025, 4:05 PM EST - 23 days ago

Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Alpha Tau to Participate at Jefferies Global Healthcare Conference in London

Nov 11, 2025, 8:30 AM EST - 4 weeks ago

Alpha Tau to Participate at Jefferies Global Healthcare Conference in London

Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness

Oct 21, 2025, 8:30 AM EDT - 7 weeks ago

Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness

Altamirano PLLC Issues Notice to Inspired Healthcare Capital (IHC) Investors on Recovery Options

Oct 17, 2025, 10:04 AM EDT - 2 months ago

Altamirano PLLC Issues Notice to Inspired Healthcare Capital (IHC) Investors on Recovery Options

Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology

Oct 16, 2025, 11:55 AM EDT - 2 months ago

Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology

Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial

Sep 2, 2025, 8:30 AM EDT - 3 months ago

Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial

Alpha Tau to Participate in Five September Investor Conferences

Aug 27, 2025, 8:30 AM EDT - 3 months ago

Alpha Tau to Participate in Five September Investor Conferences

Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 11, 2025, 4:02 PM EDT - 4 months ago

Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

Jul 25, 2025, 9:04 AM EDT - 5 months ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

May 19, 2025, 4:01 PM EDT - 7 months ago

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors

May 12, 2025, 4:01 PM EDT - 7 months ago

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors

Alpha Tau to Participate in May Investor Conferences

May 6, 2025, 8:30 AM EDT - 7 months ago

Alpha Tau to Participate in May Investor Conferences

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

Apr 28, 2025, 9:00 AM EDT - 8 months ago

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

ORMP

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical

Apr 28, 2025, 9:00 AM EDT - 8 months ago

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical

ORMP

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

Apr 2, 2025, 8:30 AM EDT - 9 months ago

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 4:02 PM EDT - 9 months ago

Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

Feb 24, 2025, 8:30 AM EST - 10 months ago

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day

Jan 27, 2025, 9:00 AM EST - 11 months ago

Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

Dec 18, 2024, 8:30 AM EST - 1 year ago

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

Dec 17, 2024, 9:00 AM EST - 1 year ago

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 11, 2024, 8:30 AM EST - 1 year ago

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Alpha Tau to Participate in Ladenburg's Oncology Innovators & Investors Symposium

Dec 6, 2024, 8:30 AM EST - 1 year ago

Alpha Tau to Participate in Ladenburg's Oncology Innovators & Investors Symposium

Alpha Tau to Participate in Citi's 2024 Global Healthcare Conference and Piper Sandler's 36th Annual Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 1 year ago

Alpha Tau to Participate in Citi's 2024 Global Healthcare Conference and Piper Sandler's 36th Annual Healthcare Conference

Alpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

Oct 21, 2024, 8:30 AM EDT - 1 year ago

Alpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

Alpha Tau Treats First Patient with Recurrent Lung Cancer

Oct 10, 2024, 8:30 AM EDT - 1 year ago

Alpha Tau Treats First Patient with Recurrent Lung Cancer

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

Sep 20, 2024, 8:30 AM EDT - 1 year ago

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference

Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 4:02 PM EDT - 1 year ago

Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

Jun 25, 2024, 8:30 AM EDT - 1 year ago

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

Alpha Tau to Present at the Jefferies Global Healthcare Conference

May 21, 2024, 8:45 AM EDT - 1 year ago

Alpha Tau to Present at the Jefferies Global Healthcare Conference

Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 20, 2024, 4:01 PM EDT - 1 year ago

Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update

Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer

May 13, 2024, 8:30 AM EDT - 1 year ago

Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer

Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow

May 6, 2024, 8:30 AM EDT - 1 year ago

Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

Mar 25, 2024, 8:50 AM EDT - 1 year ago

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

Mar 7, 2024, 4:01 PM EST - 1 year ago

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

Feb 26, 2024, 8:30 AM EST - 1 year ago

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 20, 2023, 9:15 AM EST - 2 years ago

Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Alpha Tau to Participate in Sidoti Small-Cap Conference

Nov 29, 2023, 8:30 AM EST - 2 years ago

Alpha Tau to Participate in Sidoti Small-Cap Conference

Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer

Nov 28, 2023, 8:30 AM EST - 2 years ago

Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

Nov 20, 2023, 8:30 AM EST - 2 years ago

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 16, 2023, 4:30 PM EST - 2 years ago

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer

Nov 13, 2023, 8:00 AM EST - 2 years ago

Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer

Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility

Oct 30, 2023, 8:30 AM EDT - 2 years ago

Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility

Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical Center

Sep 14, 2023, 8:30 AM EDT - 2 years ago

Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical Center

Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 28, 2023, 4:02 PM EDT - 2 years ago

Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update

Alpha Tau Medical to Participate in September Investor Conferences

Aug 24, 2023, 8:00 AM EDT - 2 years ago

Alpha Tau Medical to Participate in September Investor Conferences

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

Aug 17, 2023, 5:00 PM EDT - 2 years ago

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023

Aug 2, 2023, 9:00 AM EDT - 2 years ago

Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023

Alpha Tau Medical to Participate in June Investor Conferences

May 24, 2023, 4:01 PM EDT - 2 years ago

Alpha Tau Medical to Participate in June Investor Conferences

StockScanners
StockScanners Dec. 13 at 8:34 PM
$DRTS reached 5.49
0 · Reply
WeedMan5000
WeedMan5000 Dec. 12 at 8:17 PM
$DRTS 1m volume sends this thing .20c swings, insane price action , an ounce of any volume and we might see a move here
0 · Reply
Freddie___Mac
Freddie___Mac Dec. 12 at 2:35 PM
$DRTS low liquidity as insiders own a lot. Just the CEO own about 15% of the company... which is ofc a positive indication
0 · Reply
StonkCrasher420
StonkCrasher420 Dec. 11 at 5:02 PM
$DRTS Showing a lot of strength here. Consolidation in this range and a push to $7-$8 on the next wave of news would be fantastic
1 · Reply
BuyZoneSn1perz
BuyZoneSn1perz Dec. 11 at 12:12 PM
$DRTS low-liquidity setup, if bids keep absorbing sells this coil could resolve up
0 · Reply
Greenpa
Greenpa Dec. 11 at 12:38 AM
$DRTS If Sidoti conference was recorded, I urge a listen by Citi and retail. Any of prostate, pancreatic and gioblastoma would be epic. Two or more is not out of the question given initial data. It is the abscopal effect that would enable a very interesting pathway for treatment of solid and difficult to treat and/or resect tumors.
2 · Reply
SkylineX88v
SkylineX88v Dec. 10 at 9:09 PM
$DRTS low-liquidity setup, if bids keep absorbing sells this coil could resolve up
0 · Reply
Greenpa
Greenpa Dec. 10 at 8:45 PM
$DRTS Why would anyone pay attention to Citi lowering target to $7 following successful administration of localized alpha radiation for otherwise incurable brain tumors? Which hedge fund clients of Cit want in?
0 · Reply
WallStWireAds
WallStWireAds Dec. 10 at 7:38 PM
$DRTS
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 7:14 PM
Citigroup has adjusted their stance on Alpha Tau Medical ( $DRTS ), setting the rating to Buy with a target price of 8 → 7.
1 · Reply
Sidoti
Sidoti Dec. 10 at 6:43 PM
The Alpha Tau ($DRTS) Management Team presented today at the Sidoti Year End Virtual Conference. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_1ow9W3fMRPyM3pVjhEf6uA
0 · Reply
Khaled43
Khaled43 Dec. 10 at 6:10 PM
$ABVE $CNCK $DRTS $ONCO Onco 🔥🔥🔥🔥
0 · Reply
OneCandle_1
OneCandle_1 Dec. 10 at 5:09 PM
$DRTS low-liquidity setup, if bids keep absorbing sells this coil could resolve up
0 · Reply
annee33
annee33 Dec. 10 at 4:18 PM
$SLS take a look at $DRTS while the $SLS accumulation continues
0 · Reply
WallStWireAds
WallStWireAds Dec. 10 at 3:31 PM
$DRTS https://markets.businessinsider.com/news/currencies/alpha-tau-medical-just-treated-its-first-brain-tumor-patient-and-it-could-mark-an-inflection-point-for-the-company-nasdaq-drts-1035633634
0 · Reply
PaulLaurent
PaulLaurent Dec. 10 at 6:53 AM
🚀📈 Top Gainers 📈🚀AH $ASPC $HSPO $DRTS $SUGP $VELO
0 · Reply
StockScanners
StockScanners Dec. 10 at 2:52 AM
$DRTS keep watch if this holds above 4.10
0 · Reply
DaBullRunner
DaBullRunner Dec. 10 at 1:57 AM
🏆 THE INSANE SANTA RALLY CONTINUES 🏆 If you’re reading this just know that there are opportunities to make LIFE CHANGING gains EVERY DAY Bull market, Bear market… it doesn’t matter This market lately is designed to have 100% runners almost consistently You just need to know how to play the game and be in the know BEFORE the crowd And doing this for well over 20 years has given me the tools to understand the market behavior You seen my results I have NOTHING to prove Now my focus shifts to YOU I want to CHANGE lives I have changed many lives There is no feeling like it And I’m here to do it again So LETS GO!!!!!!!!! I wish each one of you reading this a successful new year, and beyond ❤️ $ASPC $ENVB $GWAV $AHT $DRTS see you on tomorrow!
0 · Reply
DaBullRunner
DaBullRunner Dec. 10 at 12:56 AM
$ENSC 🚨LAST CALL🚨 BEFORE THIS TAKES OFF👇 $GWAV $ENVB $DRTS $SUGP see you tomorrow
1 · Reply
DaBullRunner
DaBullRunner Dec. 10 at 12:51 AM
$ENSC is the perfect sympathy play for $ENVB imo ENSC adding this before the masses arrives👇 $DRTS $GWAV $AHT $ASPC watching into close
0 · Reply
DaBullRunner
DaBullRunner Dec. 10 at 12:41 AM
$ENVB there it goes again… If you missed my call on ENVB 🚨ENSC🚨adding this before the masses arrive 👇 $5-10 potential 🎯✅ $DRTS $GWAV $CVU $SUGP watching into the close
1 · Reply
DaBullRunner
DaBullRunner Dec. 10 at 12:26 AM
$ENVB there it goes again… the reversal…. If you missed my call on ENVB 🚨ENSC🚨adding this before the masses arrive 👇 $DRTS $GWAV $SUGP $AFJK watching
0 · Reply